THERAPEUTIC CLASS

Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied in Portugal

---

Pre-eclampsia and eclampsia are two hypertensive disorders of pregnancy, considered major causes of maternal and perinatal death worldwide. Pre-eclampsia is a multisystemic disease characterized by the development of hypertension after 20 weeks of gestation, with the presence of proteinuria or, in its absence, of signs or symptoms indicative of target organ injury. Eclampsia
represents the consequence of brain injuries caused by pre-eclampsia. The correct diagnosis and classification of the disease are essential, since the therapies for the mild and severe forms of pre-eclampsia are different. Thus, this review aims to describe the most advisable antepartum pharmacotherapy for pre-eclampsia and eclampsia applied in Portugal and based on several national and international available guidelines.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Folamil Group
Provula
Lycoxy
Ascavin
HBIG
Pregnolin
Inbumin
Gynaecology & Reproductive System
Posafit
Laktafit
Ossoral 200
Fladystin

Specific Detail Info

J. Cardiovasc. Dev. Dis. 2018;5:3

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment